These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31244287)

  • 1. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.
    Negi RR; Rana SV; Gupta V; Gupta R; Chadha VD; Prasad KK; Dhawan DK
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1675-1681. PubMed ID: 31244287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer.
    Hamaya Y; Yoshida K; Takai T; Ikuma M; Hishida A; Kanaoka S
    Br J Cancer; 2010 Mar; 102(5):916-21. PubMed ID: 20145612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer.
    Konturek PC; Rembiasz K; Burnat G; Konturek SJ; Tusinela M; Bielanski W; Rehfeld J; Karcz D; Hahn E
    Dig Dis Sci; 2006 Apr; 51(4):779-87. PubMed ID: 16615003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
    Jin M; Long ZW; Yang J; Lin X
    Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of COX-2 and MMP-13 expressions with gastric cancer and their effects on prognosis.
    Ren J; Liu J; Sui X
    J BUON; 2019; 24(1):187-193. PubMed ID: 30941969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of COX-2 mRNA in colorectal cancer.
    Roelofs HM; Te Morsche RH; van Heumen BW; Nagengast FM; Peters WH
    BMC Gastroenterol; 2014 Jan; 14():1. PubMed ID: 24383454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cyclooxygenase-2 over-expression on the prognosis of colorectal cancer patients. An experience from Western Saudi Arabia.
    Albasri AM; Elkablawy MA; Hussainy AS; Yousif HM; Alhujaily AS
    Saudi Med J; 2018 Aug; 39(8):773-780. PubMed ID: 30106414
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Fredericks E; Dealtry G; Roux S
    Can J Gastroenterol Hepatol; 2018; 2018():4379673. PubMed ID: 30186819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and association of carbonic anhydrase IX and cyclooxygenase-2 in colorectal cancer.
    Tupá V; Drahošová S; Grendár M; Adamkov M
    Pathol Res Pract; 2019 Apr; 215(4):705-711. PubMed ID: 30638861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlated non-nuclear COX2 and low HER2 expression confers a good prognosis in colorectal cancer.
    Zhou FF; Huang R; Jiang J; Zeng XH; Zou SQ
    Saudi J Gastroenterol; 2018; 24(5):301-306. PubMed ID: 29873317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.
    Kasprzak A; Szaflarski W; Szmeja J; Andrzejewska M; Przybyszewska W; Kaczmarek E; Koczorowska M; Kościński T; Zabel M; Drews M
    Int J Oncol; 2013 Jan; 42(1):305-16. PubMed ID: 23165777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
    Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
    World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels.
    Vogiagis D; Brown W; Glare EM; O'Brien PE
    Carcinogenesis; 2001 Jun; 22(6):869-74. PubMed ID: 11375891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of adiponectin in early stage of colorectal carcinogenesis.
    Tae CH; Kim SE; Jung SA; Joo YH; Shim KN; Jung HK; Kim TH; Cho MS; Kim KH; Kim JS
    BMC Cancer; 2014 Nov; 14():811. PubMed ID: 25370174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1260b is a Potential Prognostic Biomarker in Colorectal Cancer.
    Liu DR; Guan QL; Gao MT; Jiang L; Kang HX
    Med Sci Monit; 2016 Jul; 22():2417-23. PubMed ID: 27399918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
    Gao M; Zhang X; Li D; He P; Tian W; Zeng B
    Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.